We need a mind-shift in how medicine spending is weighed

The State’s pricing deal with the pharmaceutical industry ends this year, and the funding of innovation must become a priority, if patients here are to have the early access that patients elsewhere in western Europe have, says Bernard Mallee

We need a mind-shift in how medicine spending is weighed

The State’s pricing deal with the pharmaceutical industry ends this year, and the funding of innovation must become a priority, if patients here are to have the early access that patients elsewhere in western Europe have, says Bernard Mallee

For 50 years, Ireland’s pharmaceutical industry has been attracting major investments in manufacturing and research, creating tens of thousands of jobs and supplying medicines for complex illnesses.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Revoiced

Newsletter

Sign up to the best reads of the week from irishexaminer.com selected just for you.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited